Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq ...

The United States market has experienced a flat performance over the last week but has seen an 8.1% increase over the past year with earnings projected to grow by 14% annually. In this environment ...